JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$3.21B |
| 2 |
Arthur J. Gallagher & Co
AJG
|
+$2.24B |
| 3 |
Walt Disney
DIS
|
+$2.18B |
| 4 |
Walmart Inc
WMT
|
+$1.96B |
| 5 |
McDonald's
MCD
|
+$1.91B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$2.77B |
| 2 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$2.64B |
| 3 |
Vanguard Long-Term Treasury ETF
VGLT
|
+$2.5B |
| 4 |
iShares Broad USD High Yield Corporate Bond ETF
USHY
|
+$2.23B |
| 5 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.06B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 24.61% |
| 2 | Technology | 23.17% |
| 3 | Financials | 10.12% |
| 4 | Consumer Discretionary | 9.84% |
| 5 | Healthcare | 7.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
6001
Amprius Technologies
AMPX
$1.4B
| $21K | ﹤0.01% |
7,510
-19,531
| -72% | -$34.1K |
2022 Q4
8 quarters
|
|
6002
Fidus Investment
FDUS
$770M
| $21K | ﹤0.01% |
1,000
| – | – |
2018 Q1
27 quarters
|
|
6003
iShares Asia 50 ETF
AIA
$4.95B
| $20.4K | ﹤0.01% |
+301
| New | +$21.5K |
2024 Q4
0 quarters
|
|
6004
Ternium
TX
$10.9B
| $20.4K | ﹤0.01% |
701
-189
| -21% | -$6.33K |
2015 Q4
36 quarters
|
|
|
ABK
6005
CALL
DELISTED
Ambac Financial Group
ABK
| $20.2K | ﹤0.01% |
+1,600
| New | +$20.2K |
2024 Q4
0 quarters
|
|
6006
Innovator Defined Wealth Shield ETF
BALT
$2.98B
| $19.9K | ﹤0.01% |
634
+103
| +19% | +$3.21K |
2023 Q1
7 quarters
|
|
6007
Northern Trust Ultra-Short Fixed Income ETF
RAVI
$1.58B
| $19.7K | ﹤0.01% |
262
+52
| +25% | +$3.92K |
2024 Q1
3 quarters
|
|
6008
First Trust Energy AlphaDEX Fund
FXN
$367M
| $19.6K | ﹤0.01% |
+1,200
| New | +$20.2K |
2024 Q3
1 quarter
|
|
6009
Relmada Therapeutics
RLMD
$390M
| $19.6K | ﹤0.01% |
37,700
-277,359
| -88% | -$676K |
2020 Q2
18 quarters
|
|
6010
Aptevo Therapeutics
APVO
$3.19M
| $19.5K | ﹤0.01% |
+13
| New | +$37.4K |
2023 Q3
5 quarters
|
|
|
SWZ
6011
Swiss Helvetia Fund
SWZ
$74.2M
| $19.3K | ﹤0.01% |
2,581
| – | – |
2015 Q4
36 quarters
|
|
6012
Urban One Class A
UONE
$18.5M
| $19.3K | ﹤0.01% |
1,255
+9
| +0.7% | +$136 |
2022 Q2
10 quarters
|
|
|
WTPI
6013
WisdomTree Equity Premium Income Fund
WTPI
$541M
| $19.3K | ﹤0.01% |
586
-19
| -3% | -$639 |
2020 Q1
19 quarters
|
|
6014
First Trust Multi Cap Value AlphaDEX Fund
FAB
$159M
| $19.3K | ﹤0.01% |
234
| – | – |
2023 Q1
7 quarters
|
|
|
BDMDW
6015
Baird Medical Investment Holdings Warrant
BDMDW
| – | – |
0
| – | – |
2024 Q4
0 quarters
|
|
6016
Simplify US Equity PLUS Downside Convexity ETF
SPD
$101M
| $19.2K | ﹤0.01% |
+575
| New | +$19.6K |
2024 Q4
0 quarters
|
|
6017
Silicom
SILC
$308M
| $19.2K | ﹤0.01% |
1,175
+132
| +13% | +$1.87K |
2024 Q2
2 quarters
|
|
6018
Annovis Bio
ANVS
$49.9M
| $19.1K | ﹤0.01% |
3,800
| – | – |
2024 Q3
1 quarter
|
|
6019
Teucrium Wheat Fund
WEAT
$294M
| $19K | ﹤0.01% |
+789
| New | +$19.8K |
2024 Q4
0 quarters
|
|
|
GRVY
6020
GRAVITY
GRVY
$472M
| $18.9K | ﹤0.01% |
300
-183
| -38% | -$11.7K |
2023 Q4
4 quarters
|
|
6021
FT Vest US Small Cap Moderate Buffer ETF August
SAUG
$122M
| $18.9K | ﹤0.01% |
+801
| New | +$19K |
2024 Q4
0 quarters
|
|
6022
Citizens
CIA
$176M
| $18.9K | ﹤0.01% |
4,705
+4,499
| +2,184% | +$20.2K |
2023 Q3
5 quarters
|
|
6023
iShares S&P India Nifty 50 Index Fund
INDY
$494M
| $18.7K | ﹤0.01% |
368
-440
| -54% | -$23.4K |
2017 Q2
30 quarters
|
|
6024
Franklin FTSE United Kingdom ETF
FLGB
$841M
| $18.7K | ﹤0.01% |
715
+123
| +21% | +$3.37K |
2023 Q1
7 quarters
|
|
6025
State Street SPDR S&P Kensho New Economies Composite ETF
KOMP
$2.64B
| $18.7K | ﹤0.01% |
368
-4,222
| -92% | -$218K |
2023 Q4
4 quarters
|
|
Similar funds
JP Morgan Chase's Q4 2024 Portfolio in Review
As of Q4 2024, JP Morgan Chase held 7,917 positions worth $1.34T, up 2.1% from $1.32T the previous quarter. Its ten largest holdings account for 24% of the portfolio.
JP Morgan Chase's Q4 2024 filing shows 509 new, 3,351 increased, 2,465 reduced and 522 closed positions. Its largest new stake was Primo Brands: 3,989,501 shares worth $123M. The largest sale was Eli Lilly, an estimated $2.77B.
By sector, the portfolio is most concentrated in Miscellaneous at 25% of assets, up from 24% a quarter earlier, followed by Technology and Financials.
- JP Morgan Chase's largest Q4 2024 buy was Primo Brands: 3,989,501 shares worth $123M.
- JP Morgan Chase added most to Broadcom in Q4 2024, an estimated $3.21B increase.
- JP Morgan Chase's biggest Q4 2024 reduction was Eli Lilly, cutting an estimated $2.77B.
- JP Morgan Chase fully exited Stericycle Inc in Q4 2024, selling an estimated $183M.
- JP Morgan Chase's ten largest holdings make up 24% of its $1.34T portfolio in Q4 2024.
- JP Morgan Chase opened 509 new positions and closed 522 in Q4 2024.
- JP Morgan Chase's portfolio value rose 2.1% quarter-over-quarter to $1.34T.
Based on JP Morgan Chase's 13F filing for Q4 2024, filed 12 Feb 2025.